Allogeneic Cell Therapy Devices Market By Therapy Type (Stem Cell Therapies, Non-stem Cell Therapies), By Therapeutic Area (Hematological Disorders, Dermatological Disorders, Others), By End-User (Hospitals & Clinics, Research Institutes & Academic Centers, Biotechnology & Pharmaceutical Companies, Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: March 2024
- Report ID: 117463
- Number of Pages: 265
- Format:
-
-
-
- Novartis AG Company Profile
- Gilead Sciences, Inc.
- Celgene Corporation
- Bluebird Bio, Inc.
- Pfizer Inc Company Profile
- Allogene Therapeutics
- Other Key Players
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible